NRG4

Chr 15

neuregulin 4

Also known as: HRG4

The neuregulins, including NRG4, activate type-1 growth factor receptors (see EGFR; MIM 131550) to initiating cell-to-cell signaling through tyrosine phosphorylation (Harari et al., 1999 [PubMed 10348342]).[supplied by OMIM, Mar 2008]

OMIMResearchGenerating clinical summary…
0
Active trials
41
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.33
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.33LOEUF
pLI 0.028
Z-score 1.07
OE 0.52 (0.23–1.33)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.41Z-score
OE missense 0.86 (0.69–1.07)
54 obs / 63.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.52 (0.23–1.33)
0≤0.351.4
Missense OE?0.86 (0.69–1.07)
0≤0.61.4
Synonymous OE?0.93
0≤1.21.6
LoF obs/exp: 3 / 5.8Missense obs/exp: 54 / 63.1Syn Z: 0.28

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

NRG4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →